Home Your basket
• Time-intensity trade of b...
   Price 10.50 €
• Advantages of combined th...
   Price 10.50 €
• Face and neck lift using ...
   Price 14.00 €
• Hearing aid : practical a...
   Price 8.50 €
• Art and nose....
   Price 8.50 €
• Evaluation of the use of ...
   Price 8.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• Vibrant Soundbridge for h...
   Price 10.50 €
• Bilateral facial nerve pa...
   Price 5.50 €
• Temporal lift...
   Price 10.50 €
• Aspects of ageing on prof...
   Price 12.00 €
• Nasal septal abscess: A c...
   Price 5.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Reliability of CT-Scan in...
   Price 8.50 €
• Epistaxis and hospitalisa...
   Price 10.50 €
• Parapharyngeal tumours: M...
   Price 10.50 €
• Carotid body paragangliom...
   Price 8.50 €
• Treating vertigo with ves...
   Price 10.50 €
• Petrosal presigmoid appro...
   Price 8.50 €
• Vocal fold structure and ...
   Price 10.50 €
• CT scanning in "second lo...
   Price 5.50 €
• Vestibular dysfunction af...
   Price 10.50 €
• Blepharoplasty and upper ...
   Price 10.50 €
• Hearing aid : practical a...
   Price 10.50 €
• The nasal framework in rh...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• Vestibular-evoked myogeni...
   Price 10.50 €
• Transverse maxillary defi...
   Price 8.50 €
• Resorption of cartilage g...
   Price 10.50 €
• Somatic tinnitus (review)...
   Price 12.50 €
• Prosodic features of comp...
   Price 10.50 €
• Is HIV/AIDS an independen...
   Price 10.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Sarcoidosis of the thyroi...
   Price 12.50 €
• Periphery, central and ps...
   Price 10.50 €
• Sarcomatoid carcinomas of...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• What we don’t know about ...
   Price 12.50 €
• Pulsatile tinnitus and ve...
   Price 8.50 €
• Voice Handicap Index adap...
   Price 10.50 €
• Nasal glioma, diagnosis i...
   Price 12.00 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Evaluation in clinical pr...
   Price 10.50 €
• A new case of osseointegr...
   Price 12.50 €
• Post operative Caldwell-L...
   Price 10.00 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Voice-breaking in adolesc...
   Price 10.50 €
• Balance disorders in the ...
   Price 8.50 €
• Bone-Anchored Hearing Aid...
   Price 10.50 €
• Quality of life after oro...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Acceptability of topical ...
   Price 5.50 €
• Frontal sinus osteoma com...
   Price 5.50 €
• Is coincidence detection ...
   Price 10.50 €
• Forcing the voice : the c...
   Price 5.50 €
• Implementation of the Eur...
   Price 10.50 €
• Bilateral vestibular loss...
   Price 10.50 €
• Facial nerve monitoring i...
   Price 10.50 €
• Mast cells in chronic inf...
   Price 10.50 €
• Follow up of tracheostoma...
   Price 12.00 €
• How to take a mastoid and...
   Price 8.50 €
• Stingy speakers....
   Price 5.50 €
• Ganglioneuroma in saharan...
   Price 10.00 €
• Notes on voice and speech...
   Price 8.50 €
• Role of positron emission...
   Price 15.00 €
• Analysis of the possibili...
   Price 8.50 €
• The complications of end...
   Price 8.50 €
• Facial nerve monitoring d...
   Price 12.50 €
• Plastic surgery indicatio...
   Price 10.50 €
• Adult laryngeal cavernous...
   Price 5.50 €
• Skull vibratory test in p...
   Price 10.50 €
• Signs of upper Airways di...
   Price 10.50 €
• Unilateral laryngeal para...
   Price 10.50 €
• Rhinitis and allergy test...
   Price 8.50 €
• Cochlear implantation in ...
   Price 12.50 €
• Bilateral paranasal sinus...
   Price 8.50 €
• Free sorting task of spee...
   Price 10.50 €

Total Order 745.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2004 o

ONCOLOGY

Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie’s patients and patient’s follow up with laryngeal preservation


Authors : J. P. Bessède, D. Vinh, D. Genet, N. Khalifa, K. Aubry, B. Rhein, S. Orsel, N. Tubiana-Mathieu, P. Clavère (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2004;125,2:81-88.

Article published in french
Downloadable PDF document french



Summary : Objective: To try and determine the value of chemotherapy and its subsequent effect on laryngeal preservation in patients presenting with laryngeal and pharyngeal carcinomas. One group was initially treated with surgery and radiotherapy. The second group was treated with chemotherapy and subsequent salvage surgery and/or radiotherapy. Their survival rates and laryngeal preservation rates were compared. Patients and methods: From 251 patients the authors have retrospectively studied 124 patients with induction chemotherapy. The survival rate has been compared with a control group of 127 patients who was treated by initial surgery and radiotherapy. Results: The survival rate at 5 years for the patients initialy treated by surgery and radiotherapy was 64.1%. The survival for patients with a total clinical response following chemotherapy was 49.8% at 5 years. Survival with no total clinical response following chemotherapy treated by secondary radiotherapy was 25.7% at 3 years. The initial rate of laryngeal preservation is 32.2% but this rate fell to 22% after local recurrencies. Conclusion: The group with total clinical response after induction chemotherapy with laryngeal preservation have a non significantly difference in their survival compared with the group initially treated by surgery and radiotherapy. In contrary patients with non complete clinical response have a survival of 25.7% at 3 years. The rate of local recurrency of patients with laryngeal preservation is 32.5% and gives a finally rate of laryngeal preservation of 21%. These recurrencies decrease the survival rate.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE